Director, Movement Disorders Program, University of California, Irvine
Neurology
Dr. Neal S. Hermanowicz, MD
|
|
Give Review
Neal Hermanowicz is an expert in the field of Neurology. He researched medicine at Temple University School of Medicine. He has 19 awards "Top Doctors:LA Area", "Top Doctors:San Diego Area", "Best Doctor, Neurology", "Palm Springs Life Magazine", "Top Doctors:Southern California", "Faculty Teaching", "Faculty Appreciation", "Pioneer Hall of Fame", "Dystonia Doctor of Excellence", "Lamport Award for Medical Student Research", "Clinical Excellence", "Bachelor of Science with Highest Distinction in the Chemistry", "Phi Lambda Upsilon", "Phi Kappa Phi, Honor Society", "Super Doctor", "Top MD", "President", "Orange County Physician of Excellence" and "Physician of Excellence". Neal Hermanowicz is also a published doctor. He has 29 paper published. The most recent paper is: The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease. He is registered with Medicare.
Publications
- The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's Disease.
- Frameless Stereotactic Robot-Assisted Subthalamic Nucleus Deep Brain Stimulation: Case Report.
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit.
- A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington Disease.
- Creation of an open-access, mutation-defined fibroblast resource for neurological Disease research.
- Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's di...
- Predictors of time to requiring dopaminergic treatment in 2 Parkinson''s Disease cohorts.
- A recommended scale for cognitive screening in clinical trials of Parkinson''s Disease.
- A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.
- Cancer incidence in a trial of an antiapoptotic agent for Parkinson's Disease.
- Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with Multiple sclerosis.
- OnabotulinumtoxinA for treatment of chronic Migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
- Increased melanoma risk in Parkinson Disease: a prospective clinicopathological study.
- Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
- A comparison of treatment thresholds in two large Parkinson's Disease clinical trial cohorts.
- Increased prevalence of val(66)met BDNF genotype among subjects with cervical Dystonia.
- A longitudinal program for biomarker development in Parkinson''s Disease: a feasibility study.
- A double-blind, delayed-start trial of rasagiline in Parkinson's Disease.
- A forty-five year follow-up EEG study of Qigong practice.
- Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson Disease.
- Cannabinoid rescue of striatal progenitor cells in chronic Borna Disease viral encephalitis in rats.
- Serum urate as a predictor of clinical and radiographic progression in Parkinson Disease.
- Fatal gastroparesis in a patient with Parkinson's Disease.
- Rasagiline as a therapy for Parkinson's Disease (PD).
- Drug therapy for Parkinson's Disease.
- Reduction of EEG myogenic artifact with botulinum toxin during video-EEG monitoring.
- Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with Multiple sclerosis.
- A blind man with Parkinson's Disease, visual hallucinations, and Capgras syndrome.
Schools
Temple University School Of Medicine
University Of Wisconsin Madison
University Of Michigan
Procedures Preformed
- Collagen Injection
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Hylaform Injection
- View All
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:San Diego Area
- Best Doctor, Neurology
- Palm Springs Life Magazine
- Top Doctors:Southern California
- Faculty Teaching
- Faculty Appreciation
- Pioneer Hall of Fame
- Dystonia Doctor of Excellence
- Lamport Award for Medical Student Research
- Clinical Excellence
- Bachelor of Science with Highest Distinction in the Chemistry
- Phi Lambda Upsilon
- Phi Kappa Phi, Honor Society
- Super Doctor
- Top MD
- President
- Orange County Physician of Excellence
- Physician of Excellence
Education
-
University of Michigan Hospitals and Health Centers -
University of Wisconsin -
Temple University School of Medicine -
University of Illinois
Hospital
-
UC Irvine Medical Center
Drug Facts
| NPI NUMBER | 1023198181 | |
| NPPES Provider LastName | HERMANOWICZ | |
| NPPES Provider FirstName | NEAL | |
| NPPES Provider ZIPCode | 92868 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 6726.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023198181 |
| Last Name Of The Provider | HERMANOWICZ |
| First Name Of The Provider | NEAL |
| View All |
Similar Doctors
|
Dr. Malcolm B. Dick, PHD |
|
|
Dr. Diane M. Stein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark S. Van Houten, MD |
|
|
Dr. Mitchell F. Brin, MD |
|
|
Dr. Lester M. Hershman, MD |
|
|
Dr. Aimee L. Pierce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle H. Molina, PHD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parissa J. Hagh, MD |
|
|
Dr. Jay Shah, MD |